MO01.40 Trilaciclib has Myelopreservation Benefits in Patients with Small Cell Lung Cancer Treated with Chemotherapy, Irrespective of Age

Autor:	Donald A. Richards, R. Agajanian, C. Ikpeazu, D. Berz, Joyce M Antal, M.M. Tarruella, Didier Verhoeven, Hongbin Chen, Yili Pritchett, Rajesh K. Malik, Maen A. Hussein, T. Beck
Rok vydání:	2021
Předmět:	Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty Chemotherapy business.industry Internal medicine medicine.medical_treatment medicine In patient Non small cell business
Zdroj:	Journal of Thoracic Oncology. 16:S32-S33
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2020.10.144
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e163017108f9b30be781f6fccb62e7c5 https://doi.org/10.1016/j.jtho.2020.10.144 Zobrazit plný text záznamu